Clinical Trial Update: A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dolutegravir in HIV-infected subjects with treatment failure on an integrase inhibitor–containing regimen has completed; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tivicay (dolutegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 3 | Status: COMPLETED | Results posted: 2014-07-21